Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers

  Breast Cancer

  Free Subscription

Articles published in Gene

Retrieve available abstracts of 90 articles:
HTML format

Single Articles

    July 2021
  1. MURAD R, Avanes A, Ma X, Geng S, et al
    Transcriptome and chromatin landscape changes associated with trastuzumab resistance in HER2+ breast cancer cells.
    Gene. 2021 Jul 2:145808. doi: 10.1016/j.gene.2021.145808.
    PubMed     Abstract available

  2. FENG Y, Cai H, Huang X, Li Z, et al
    Active MT1-MMP is tethered to collagen fibers in DDR2-containing remnants.
    Gene. 2021;788:145673.
    PubMed     Abstract available

    June 2021
  3. GYAN E, Owiredu WKBA, Ahenkorah-Fondjo L, Jackson AM, et al
    A review of the racial heterogeneity of breast cancer stem cells.
    Gene. 2021 Jun 28:145805. doi: 10.1016/j.gene.2021.145805.
    PubMed     Abstract available

    May 2021
  4. KUMAR A, Dhillon A, Manjegowda MC, Singh N, et al
    Estrogen suppresses HOXB2 expression via ERalpha in breast cancer cells.
    Gene. 2021 May 29:145746. doi: 10.1016/j.gene.2021.145746.
    PubMed     Abstract available

  5. ROYCHOWDHURY A, Jondhale M, Saldanha E, Ghosh D, et al
    Landscape of Toll-like receptors expression in tumor microenvironment of Triple Negative Breast Cancer (TNBC): distinct roles of TLR4 and TLR8.
    Gene. 2021 May 19:145728. doi: 10.1016/j.gene.2021.145728.
    PubMed     Abstract available

  6. PARAMASIVAM OVIYA R, Gopal G, Singh Shirley S, Sridevi V, et al
    Mitochondrial Ribosomal Small Subunit proteins (MRPS) MRPS6 and MRPS23 show dysregulation in breast cancer affecting tumorigenic cellular processes.
    Gene. 2021 May 5:145697. doi: 10.1016/j.gene.2021.145697.
    PubMed     Abstract available

    March 2021
  7. JANANI SK, Dhanabal SP, Sureshkumar R, Nikitha Upadhyayula SS, et al
    Guardian of genome on the tract: wild type p53-mdm2 complex inhibition in healing the breast cancer.
    Gene. 2021 Mar 31:145616. doi: 10.1016/j.gene.2021.145616.
    PubMed     Abstract available

    January 2021
  8. TANDON M, Othman AH, Winogradzki M, Pratap J, et al
    Bone metastatic breast cancer cells display downregulation of PKC-zeta with enhanced glutamine metabolism.
    Gene. 2021 Jan 11:145419. doi: 10.1016/j.gene.2021.145419.
    PubMed     Abstract available

    November 2020
  9. KANUMURI R, Saravanan R, Pavithra V, Sundaram S, et al
    Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers.
    Gene. 2020;760:144991.
    PubMed     Abstract available

    September 2020
  10. ZHANG XY, Mao L
    Circular RNA Circ_0000442 Acts as a Sponge of MiR-148b-3p to Suppress Breast Cancer via PTEN/PI3K/Akt Signaling Pathway.
    Gene. 2020 Sep 3:145113. doi: 10.1016/j.gene.2020.145113.
    PubMed     Abstract available

    August 2020
  11. WANG J, Yang Z, Zhang C, Ouyang J, et al
    A Four-Gene Signature in the Tumor Microenvironment That Significantly Associates with the Prognosis of Patients with Breast Cancer.
    Gene. 2020 Aug 10:145049. doi: 10.1016/j.gene.2020.145049.

  12. DOMINGUEZ-DE-LA-CRUZ E, de Lourdes Munoz M, Perez-Munoz A, Garcia-Hernandez N, et al
    Reduced mitochondrial DNA copy number is associated with the haplogroup, and some clinical features of breast cancer in Mexican patients.
    Gene. 2020 Aug 9:145047. doi: 10.1016/j.gene.2020.145047.
    PubMed     Abstract available

  13. RAJAGOPAL T, Seshachalam A, Akshaya RL, Kumar Rathnam K, et al
    Association of HOTAIR (rs920778 and rs1899663) and NME1 (rs16949649 and rs2302254) gene polymorphisms with breast cancer risk in India.
    Gene. 2020 Aug 8:145033. doi: 10.1016/j.gene.2020.145033.
    PubMed     Abstract available

  14. NOLAN J, Mahdi AF, Dunne CP, Kiely PA, et al
    Collagen and fibronectin promote an aggressive cancer phenotype in breast cancer cells but drive autonomous gene expression patterns.
    Gene. 2020 Aug 2:145024. doi: 10.1016/j.gene.2020.145024.
    PubMed     Abstract available

    July 2020
  15. JAMALZEI B, Karami Tehrani FS, Atri M
    Evaluation of LDL receptor and Scavenger Receptor, Class B, Type 1 in the malignant and benign breast tumors: The correlation with the expression of miR-199a-5p, miR-199b-5p and miR-455-5p.
    Gene. 2020;749:144720.
    PubMed     Abstract available

  16. XU T, Zhang S, Qiu D, Li X, et al
    Association between matrix metalloproteinase 9 polymorphisms and breast cancer risk: An updated meta-analysis and trial sequential analysis.
    Gene. 2020;759:144972.
    PubMed     Abstract available

  17. KUSOGLU A, Bagca BG, Ay NPO, Gunduz C, et al
    Telomerase inhibition regulates EMT mechanism in breast cancer stem cells.
    Gene. 2020 Jul 29:145001. doi: 10.1016/j.gene.2020.145001.
    PubMed     Abstract available

  18. GUO L, Chen B, Zhang G, Wang Y, et al
    The transcription factor CBFB mutations indicate an improved survival in HR+/HER2- breast cancer.
    Gene. 2020 Jul 22:144970. doi: 10.1016/j.gene.2020.144970.
    PubMed     Abstract available

  19. DU JX, Chen C, Luo YH, Cai JL, et al
    Establishment and validation of a novel autophagy-related gene signature for patients with breast cancer.
    Gene. 2020 Jul 21:144974. doi: 10.1016/j.gene.2020.144974.
    PubMed     Abstract available

    June 2020
  20. CAI Z, Zhang M, Boafo Kwantwi L, Bi X, et al
    Breast cancer cells promote self-migration by secreting interleukin 8 to induce NET formation.
    Gene. 2020 Jun 13:144902. doi: 10.1016/j.gene.2020.144902.

  21. RAHMANI F, Taddayon Tabrizi A, Hashemian P, Alijannejad S, et al
    Role of regulatory miRNAs of the Wnt/ beta-catenin signaling pathway in tumorigenesis of breast cancer.
    Gene. 2020 Jun 10:144892. doi: 10.1016/j.gene.2020.144892.
    PubMed     Abstract available

    May 2020
  22. TENHUNEN J, Kokkola T, Huovinen M, Rahnasto-Rilla M, et al
    Impact of structurally diverse BET inhibitors on SIRT1.
    Gene. 2020;741:144558.
    PubMed     Abstract available

  23. JIA R, Zhao H, Jia M
    Identification of co-expression modules and potential biomarkers of breast cancer by WGCNA.
    Gene. 2020;750:144757.
    PubMed     Abstract available

    April 2020
  24. SUN L, Shi C, Liu S, Zhang E, et al
    Overexpression of NuSAP1 is predictive of an unfavourable prognosis and promotes proliferation and invasion of triple-negative breast cancer cells via the Wnt/beta-catenin/EMT signalling axis.
    Gene. 2020 Apr 13:144657. doi: 10.1016/j.gene.2020.144657.
    PubMed     Abstract available

    March 2020
  25. WU Y, Huang D, Zhang H, Weng X, et al
    The frequency of PTEN germline mutations in Chinese breast cancer patients: the PTEN gene may not be closely associated with breast cancer in the Chinese population.
    Gene. 2020 Mar 28:144630. doi: 10.1016/j.gene.2020.144630.
    PubMed     Abstract available

    February 2020
  26. DAI J, Chen Y, Gong Y, Gu D, et al
    Association of microRNA-27a rs895819 polymorphism with the risk of cancer: An updated meta-analysis.
    Gene. 2020;728:144185.
    PubMed     Abstract available

  27. DOULABI MSH, Ghaedi K, Ranji N, Koohpar ZK, et al
    rs1016860 of BCL2 3'UTR associates with hsa-miR-629-5p binding potential in breast cancer and gastric cancer in isfahan population.
    Gene. 2020 Feb 17:144457. doi: 10.1016/j.gene.2020.144457.
    PubMed     Abstract available

  28. RAHMANI F, Ferns GA, Talebian S, Nourbakhsh M, et al
    Role of regulatory miRNAs of the PI3K/AKT signaling pathway in the pathogenesis of breast cancer.
    Gene. 2020 Feb 8:144459. doi: 10.1016/j.gene.2020.144459.
    PubMed     Abstract available

  29. ABUBAKR BABTEEN N, Fawzy MS, Alelwani W, Ayiad Alharbi R, et al
    Signal peptide missense variant in cancer-brake gene CTLA4 and breast cancer outcomes.
    Gene. 2020 Feb 7:144435. doi: 10.1016/j.gene.2020.144435.
    PubMed     Abstract available

  30. NAJJARY S, Mohammadzadeh R, Mokhtarzadeh A, Mohammadi A, et al
    Role of miR-21 as an authentic oncogene in mediating drug resistance in breast cancer.
    Gene. 2020 Feb 5:144453. doi: 10.1016/j.gene.2020.144453.
    PubMed     Abstract available

    January 2020
  31. ZHANG H, Cui X, Cao A, Li X, et al
    ITGA3 interacts with VASP to regulate stemness and epithelial-mesenchymal transition of breast cancer cells.
    Gene. 2020 Jan 25:144396. doi: 10.1016/j.gene.2020.144396.
    PubMed     Abstract available

  32. POURBAGHER R, Akhavan-Niaki H, Jorsaraei SGA, Fattahi S, et al
    Targeting LA7 breast cancer stem cells of rat through repressing the genes of stemness-related transcription factors using three different biological fluids.
    Gene. 2020 Jan 21:144381. doi: 10.1016/j.gene.2020.144381.
    PubMed     Abstract available

  33. WANG X, Su D, Qin Z, Chen Z, et al
    Identification of FOXN4 as a tumor suppressor of breast carcinogenesis via the activation of TP53 and deactivation of Notch signaling.
    Gene. 2020;722:144057.
    PubMed     Abstract available

    December 2019
  34. DASTMALCHI N, Safaralizadeh R, Baradaran B, Hosseinpourfeizi M, et al
    An update review of deregulated tumor suppressive microRNAs and their contribution in various molecular subtypes of breast cancer.
    Gene. 2019 Dec 26:144301. doi: 10.1016/j.gene.2019.144301.
    PubMed     Abstract available

  35. XIE W, Zhang H, Qin S, Zhang J, et al
    The expression and clinical significance of secretory leukocyte proteinase inhibitor (SLPI) in mammary carcinoma using bioinformatics analysis.
    Gene. 2019;720:144088.
    PubMed     Abstract available

  36. AL-EITAN LN, Rababa'h DM
    Correlation between a variable number tandem repeat (VNTR) polymorphism in SMYD3 gene and breast cancer: a genotype-phenotype study.
    Gene. 2019 Dec 10:144281. doi: 10.1016/j.gene.2019.144281.
    PubMed     Abstract available

    November 2019
  37. MORAIS-RODRIGUES F, Silv Erio-Machado R, Kato RB, Rodrigues DLN, et al
    Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression.
    Gene. 2019 Nov 21:144168. doi: 10.1016/j.gene.2019.144168.
    PubMed     Abstract available

    September 2019
  38. QI L, Yao Y, Zhang T, Feng F, et al
    A four-mRNA model to improve the prediction of breast cancer prognosis.
    Gene. 2019 Sep 4:144100. doi: 10.1016/j.gene.2019.144100.
    PubMed     Abstract available

  39. ZOU X, Li M, Huang Z, Zhou X, et al
    Circulating miR-532-502 cluster derived from chromosome X as biomarkers for diagnosis of breast cancer.
    Gene. 2019 Sep 4:144104. doi: 10.1016/j.gene.2019.144104.
    PubMed     Abstract available

    August 2019
  40. WANG H, Xu B, Shi J
    N6-methyladenosine METTL3 promotes the breast cancer progression via targeting Bcl-2.
    Gene. 2019 Aug 24:144076. doi: 10.1016/j.gene.2019.144076.
    PubMed     Abstract available

  41. ORS KUMOGLU G, Doskaya M, Gulce Iz S
    The biomarker features of miR-145-3p determined via meta-analysis validated by qRT-PCR in metastatic cancer cell lines.
    Gene. 2019;710:341-353.
    PubMed     Abstract available

  42. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Corrigendum to "Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor" [Gene 711 (2019) 143952].
    Gene. 2019 Aug 1:144013. doi: 10.1016/j.gene.2019.144013.

    July 2019
  43. TOKGUN PE, Tokgun O, Kurt S, Tomatir AG, et al
    MYC-driven regulation of long non-coding RNA profiles in breast cancer cells.
    Gene. 2019 Jul 18:143955. doi: 10.1016/j.gene.2019.143955.
    PubMed     Abstract available

  44. RAMEZANI S, Sharafshah A, Mirzanejad L, Hadavi M, et al
    Association of PARP1 rs4653734, rs907187 and rs1136410 variants with breast cancer risk among Iranian women.
    Gene. 2019;712:143954.
    PubMed     Abstract available

    June 2019
  45. NAZIR SU, Kumar R, Singh A, Khan A, et al
    Breast cancer invasion and progression by MMP-9 through Ets-1 transcription factor.
    Gene. 2019 Jun 29:143952. doi: 10.1016/j.gene.2019.143952.
    PubMed     Abstract available

  46. YARAHMADI S, Abdolvahabi Z, Hesari Z, Tavakoli-Yaraki M, et al
    Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells.
    Gene. 2019 Jun 17. pii: S0378-1119(19)30589-X. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

  47. FENG T, Zhang P, Sun Y, Wang Y, et al
    High throughput sequencing identifies breast cancer-secreted exosomal LncRNAs initiating pulmonary pre-metastatic niche formation.
    Gene. 2019 Jun 6. pii: S0378-1119(19)30552-9. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

  48. KASA P, Farran B, Prasad GLV, Nagaraju GP, et al
    Aquaporins in female specific cancers.
    Gene. 2019;700:60-64.
    PubMed     Abstract available

    May 2019
  49. XU X, Yang J, Zhou W, Wang L, et al
    Genetic variations within alternative splicing associated genes are associated with breast cancer susceptibility in Chinese women.
    Gene. 2019 May 9. pii: S0378-1119(19)30484-6. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

    April 2019
  50. WU G, Niu M, Qin J, Wang Y, et al
    Inactivation of Rab27B-dependent signaling pathway by calycosin inhibits migration and invasion of ER-negative breast cancer cells.
    Gene. 2019 Apr 16. pii: S0378-1119(19)30344-0. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

  51. BU Y, Shi L, Yu D, Liang Z, et al
    CDCA8 is a key mediator of estrogen-stimulated cell proliferation in breast cancer cells.
    Gene. 2019;703:1-6.
    PubMed     Abstract available

    March 2019
  52. MUKUND V, Saddala MS, Farran B, Mannavarapu M, et al
    Molecular docking studies of angiogenesis target protein HIF-1alpha and genistein in breast cancer.
    Gene. 2019;701:169-172.
    PubMed     Abstract available

  53. SAFARI MR, Rezaei FM, Dehghan A, Noroozi R, et al
    Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.
    Gene. 2019 Mar 22. pii: S0378-1119(19)30293-8. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

  54. AFSHAR E, Hashemi-Arabi M, Salami S, Peirouvi T, et al
    Screening of acetaminophen-induced alterations in epithelial-to-mesenchymal transition-related expression of microRNAs in a model of stem-like triple-negative breast cancer cells: The possible functional impacts.
    Gene. 2019 Mar 18. pii: S0378-1119(19)30271-9. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

  55. ZHANG L, Chen T, Yan L, Xu H, et al
    MiR-155-3p acts as a tumor suppressor and reverses paclitaxel resistance via negative regulation of MYD88 in human breast cancer.
    Gene. 2019 Mar 13. pii: S0378-1119(19)30200-8. doi: 10.1016/j.gene.2019.
    PubMed     Abstract available

    February 2019
  56. YOUNES N, Zayed H
    Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.
    Gene. 2019;684:154-164.
    PubMed     Abstract available

    January 2019
  57. ZHONG C, Mai Y, Gao H, Zhou W, et al
    Mitochondrial targeting of TR3 is involved in TPA induced apoptosis in breast cancer cells.
    Gene. 2019 Jan 11. pii: S0378-1119(19)30032-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    November 2018
  58. LI J, Li B, Jiang Q, Zhang Y, et al
    Do genetic polymorphisms of the vitamin D receptor contribute to breast/ovarian cancer? A systematic review and network meta-analysis.
    Gene. 2018;677:211-227.
    PubMed     Abstract available

  59. ORANGI E, Motovali-Bashi M
    Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Gene. 2018;687:272-279.
    PubMed     Abstract available

    October 2018
  60. ZHOU J, Pei Y, Chen G, Cao C, et al
    SPC24 Regulates breast cancer progression by PI3K/AKT signaling.
    Gene. 2018;675:272-277.
    PubMed     Abstract available

  61. MA R, Zhai X, Zhu X, Zhang L, et al
    LINC01585 functions as a regulator of gene expression by the CAMP/CREB signaling pathway in breast cancer.
    Gene. 2018 Oct 23. pii: S0378-1119(18)31102-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  62. JAHANGIRI R, Jamialahmadi K, Gharib M, Razavi AE, et al
    Expression and clinicopathological significance of DNA methyltransferase 1, 3A and 3B in tamoxifen-treated breast cancer patients.
    Gene. 2018 Oct 22. pii: S0378-1119(18)31099-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  63. SHI S, Chen X, Liu H, Yu K, et al
    LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/beta-catenin pathway.
    Gene. 2018 Oct 6. pii: S0378-1119(18)31039-4. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    August 2018
  64. MAQBOOL SN, Nazeer HS, Rafiq M, Javed A, et al
    Bridging the gap by discerning SNPs in linkage disequilibrium and their role in breast cancer.
    Gene. 2018 Aug 14. pii: S0378-1119(18)30762-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  65. JANAKI RAMAIAH M, Vaishnave S
    BMI1 and PTEN are key determinants of breast cancer therapy: A plausible therapeutic target in breast cancer.
    Gene. 2018 Aug 7. pii: S0378-1119(18)30872-2. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    July 2018
    Tree-based machine learning algorithms identified minimal set of miRNA biomarkers for breast cancer diagnosis and molecular subtyping.
    Gene. 2018 Jul 25. pii: S0378-1119(18)30836-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  67. SADAF, Habib M, Khan MA, Najm MZ, et al
    Hypermethylated LATS2 gene with decreased expression in female breast cancer: A case control study from North India.
    Gene. 2018 Jul 12. pii: S0378-1119(18)30807-2. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  68. JIANG M, Xiao Y, Liu D, Luo N, et al
    Overexpression of long noncoding RNA LINC01296 indicates an unfavorable prognosis and promotes tumorigenesis in breast cancer.
    Gene. 2018 Jul 4. pii: S0378-1119(18)30773-X. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    June 2018
  69. AL-OTHMAN N, Hammad H, Ahram M
    Dihydrotestosterone regulates expression of CD44 via miR-328-3p in triple-negative breast cancer cells.
    Gene. 2018 Jun 28. pii: S0378-1119(18)30755-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  70. ULKER D, Ersoy YE, Gucin Z, Muslumanoglu M, et al
    Downregulation of SCARA5 may contribute to breast cancer via promoter hypermethylation.
    Gene. 2018 Jun 13. pii: S0378-1119(18)30687-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  71. HESARI Z, Nourbakhsh M, Hosseinkhani S, Abdolvahabi Z, et al
    Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells.
    Gene. 2018 Jun 7. pii: S0378-1119(18)30672-3. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    May 2018
  72. XU J, Zhang W, Tang L, Chen W, et al
    Epithelial-mesenchymal transition induced PAI-1 is associated with prognosis of triple-negative breast cancer patients.
    Gene. 2018 May 23. pii: S0378-1119(18)30586-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  73. RAHMAN S, Zayed H
    Breast cancer in the GCC countries: A focus on BRCA1/2 and non-BRCA1/2 genes.
    Gene. 2018 May 16. pii: S0378-1119(18)30534-1. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  74. BAGHI N, Bakhshinejad B, Keshavarz R, Babashah S, et al
    Dendrosomal nanocurcumin and exogenous p53 can act synergistically to elicit anticancer effects on breast cancer cells.
    Gene. 2018 May 10. pii: S0378-1119(18)30508-0. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  75. REZAIE Z, Ardeshirylajimi A, Ashkezari MD
    Improved anticancer properties of stem cells derived exosomes by prolonged release from PCL nanofibrous structure.
    Gene. 2018 May 2. pii: S0378-1119(18)30480-3. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    March 2018
  76. FEI HR, Li ZJ, Ying-Zhang, Yue-Liu, et al
    HBXIP regulates etoposide-induced cell cycle checkpoints and apoptosis in MCF-7 human breast carcinoma cells.
    Gene. 2018;647:39-47.
    PubMed     Abstract available

  77. RAGHAVAN S, Venkatraman G, Rayala SK
    Cloning and functional characterization of human Pak1 promoter by steroid hormones.
    Gene. 2018;646:120-128.
    PubMed     Abstract available

  78. XIAO B, Zhang W, Chen L, Hang J, et al
    Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
    Gene. 2018 Mar 5. pii: S0378-1119(18)30238-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    February 2018
  79. HEYDARI N, Nikbakhsh N, Sadeghi F, Farnoush N, et al
    Overexpression of serum MicroRNA-140-3p in premenopausal women with newly diagnosed breast cancer.
    Gene. 2018 Feb 20. pii: S0378-1119(18)30167-7. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  80. SINGH PK, Mistry K, Haritha C, Rank DN, et al
    Exploring the deleterious SNPs in XRCC4 gene using computational approach and studying their association with breast cancer in the population of West India.
    Gene. 2018 Feb 13. pii: S0378-1119(18)30176-8. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  81. GHALI R, Al-Mutawa MA, Al-Ansari AK, Zaied S, et al
    Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
    Gene. 2018 Feb 4. pii: S0378-1119(18)30140-9. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  82. LI XP, Lan JY, Liu DQ, Zhou H, et al
    OCA2 rs4778137 polymorphism predicts survival of breast cancer patients receiving neoadjuvant chemotherapy.
    Gene. 2018 Feb 1. pii: S0378-1119(18)30121-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    January 2018
  83. CHEN J, Jiang Y, Zhou J, Liu S, et al
    Evaluation of CpG-SNPs in miRNA promoters and risk of breast cancer.
    Gene. 2018 Jan 24. pii: S0378-1119(18)30085-4. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

  84. DANESH H, Hashemi M, Bizhani F, Hashemi SM, et al
    Association study of miR-100, miR-124-1, miR-218-2, miR-301b, miR-605, and miR-4293 polymorphisms and the risk of breast cancer in a sample of Iranian population.
    Gene. 2018 Jan 6. pii: S0378-1119(18)30032-5. doi: 10.1016/j.gene.2018.
    PubMed     Abstract available

    December 2017
  85. KAR S, Patra SK
    Overexpression of OCT4 induced by modulation of histone marks plays crucial role in breast cancer progression.
    Gene. 2017 Dec 1. pii: S0378-1119(17)31043-0. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

    November 2017
  86. KLASSEN LMB, Chequin A, Manica GCM, Biembengut IV, et al
    MMP9 gene expression regulation by intragenic epigenetic modifications in breast cancer.
    Gene. 2017 Nov 18. pii: S0378-1119(17)31018-1. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

  87. PENG R, Luo C, Guo Q, Cao J, et al
    Association analyses of genetic variants in long non-coding RNA MALAT1 with breast cancer susceptibility and mRNA expression of MALAT1 in Chinese Han population.
    Gene. 2017 Nov 13. pii: S0378-1119(17)30956-3. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

    October 2017
  88. JANAKI RAMAIAH M, Naushad SM, Lavanya PON, Gayatri A, et al
    Epigenetic regulation of miR-200 as the potential strategy for the therapy against triple-negative breast cancer.
    Gene. 2017 Oct 13. pii: S0378-1119(17)30831-4. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

  89. ZHOU L, Gao HF, Liu DS, Feng JY, et al
    Gene expression profiling of brain metastatic cell from triple negative breast cancer: Understanding the molecular events.
    Gene. 2017 Oct 9. pii: S0378-1119(17)30833-8. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

    September 2017
  90. LAHIRI DK, Maloney B, Sambamurti K
    When figures and data contradict text: MiR346 is apparently reduced in breast cancer tissue, contrary to claims by a paper's author.
    Gene. 2017 Sep 6. pii: S0378-1119(17)30646-7. doi: 10.1016/j.gene.2017.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.